title: Emerging approaches in hepatocellular carcinoma.
abstract: The incidence of hepatocellular carcinoma (HCC) is predicted to continue to increase over the next 30 years. Surgical intervention, including resection and orthotopic liver transplantation (OLT) is offered to a limited number of patients. Novel approaches to the treatment of patients with HCC are needed. This article aims to review emerging approaches in the care of the HCC patient including systemic treatment, selection of appropriate candidates for OLT, improved imaging to follow treatment response, and management pre-OLT and post-OLT.
authors: Division of Hepatology, Departments of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. lkulik@nmff.org
authors: Laura M
authors: LM
authors: Kulik
authors: Mary F
authors: MF
authors: Mulcahy
authors: Reed A
authors: RA
authors: Omary
authors: Riad
authors: R
authors: Salem
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic / Q000379:methods; D006498:Hepatectomy; D006801:Humans; D016031:Liver Transplantation; D018579:Patient Selection; D015021:Yttrium Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D015021:Yttrium Radioisotopes